Evidence map›Paper›PMID 33192474›Full record

ArticleFrontiers in aging neuroscience2020

Associating Type 2 Diabetes Risk Factor Genes and FDG-PET Brain Metabolism in Normal Aging and Alzheimer's Disease.

Scott Nugent, Olivier Potvin, Stephen C Cunnane, Ting-Huei Chen, Simon Duchesne

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in aging neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Cognitively healthy centenarians are genetically protected against Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  6. Article
  7. Diabetes and dementia: Clinical perspective, innovation, knowledge gaps.Journal of diabetes and its complications · 2022
    Review
  8. Imaging Transcriptomics of Brain Disorders.Biological psychiatry global open science · 2022
    Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Scott NugentCentre de Recherche CERVO de l'Institut Universitaire en Santé Mentale de Québec, Québec, QC, Canada.
Olivier PotvinCentre de Recherche CERVO de l'Institut Universitaire en Santé Mentale de Québec, Québec, QC, Canada.
Stephen C CunnaneResearch Center on Aging, Health and Social Sciences Center, Geriatrics Institute, Sherbrooke, QC, Canada.
Ting-Huei ChenCentre de Recherche CERVO de l'Institut Universitaire en Santé Mentale de Québec, Québec, QC, Canada.
Simon DuchesneCentre de Recherche CERVO de l'Institut Universitaire en Santé Mentale de Québec, Québec, QC, Canada.
Institut Universitaire en Santé Mentale de Québec · CAHealth and Social Services Centre University Institute of Geriatrics of Sherbrooke · CAUniversité Laval · CA

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzhermer diseasebrain metabolic imaginggene expressionnormal aging braintype 2 diabetes

Identifiers

PMID33192474
PMCPMC7661639
OpenAlexW3095055739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.